CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Ethics

ONCOLOGY. Vol. 24 No. 7
COMMENTARY 

Exploring the Interface Between Cancer and Psychiatry

By Murray Krelstein, MD | June 23, 2010

As a psychiatrist who has cancer, I have developed a deep understanding of how clinicians can help patients who are facing the complicated emotional aspects of dealing with a potentially life-threatening illness. When it comes to cancer, I have been through a lot and have learned a lot.

The Chemotherapy Experience

I have learned many things since I first heard those three dreaded words: “You have cancer.”

It would take a book to discuss them all, so I will explore only two topics…chemotherapy and people’s reaction to my having lymphoma.

All the “chemo” I received was given intravenously, so the first step was to find a relatively permanent route of access into my body. Fortunately, my veins are accessible and so a “picc” line was inserted. Finally, after three tries to insert the catheter, a radiograph showed that the tip of the line was perfectly placed right next to my heart, where it stayed throughout my hospitalizations.

At first, the catheter was somewhat annoying because it had to be handled very carefully—both by the special staff whose job it was to keep the exposed end sterile—and by me, since I had to be very careful whenever I moved. However, as time went on, my connection to this little line became deep and meaningful as I became very attached to it—both literally and figuratively. I am prone to anthropomorphizing, and I soon began to imbue this little device with great affection.

This happened because right after it was inserted, bags full of different solutions started to arrive. My line started its 24-hour-a-day job.

Of all the bags that were hung—and there were a lot—I remember most clearly the one that contained a substance so toxic that the nurses covered me with a plastic sheet and only handled the drug after they put on special gloves. There I was…receiving a solution too toxic for others to get near—and it was being delivered directly into me, next to my heart so that it could be disseminated throughout my body as quickly and directly as possible!

This experience—and many others—engendered powerful emotions. But because no psychiatrist was working with me, I had no one to talk to about what I was feeling. At the teaching hospital where I was admitted, a team of different doctors ranging in status marched in twice a day. They asked how I was feeling and marched out. They were rounding and it was clear that their mission was not to sit and talk with me. The nurses were efficient and always made sure that they were giving the correct chemo to the right person, but they also were not interested in spending any time getting to know me or learning what was in my head.

I am fortunate to have a very supportive and loving family. My wife and two children came a relatively long way to visit me every day, but they were so upset to see me lying in bed with all the bags of liquids going into my body 24-hours a day that they were in no position to be able to deal with my feelings, and I did not want to burden them any further.

One day, a clinical study organizer (a nonphysician) came in to talk with me, and I started to cry. When she saw this, I had the sense that she was ready to call for a psych consult and was considering putting me on a 5150 hold! I stopped.

If a psychiatrist had been visiting me regularly, I would have been more than eager to share my feelings—and I would have felt much better. But I quickly learned that on a “cancer ward,” feelings were not of much interest to anyone except the patient.

I did not finish the clinical trial in which I had been enrolled because the medications were too strong. I was fortunate that I did not suffer from the horrible adverse effects that I had feared so much, but my bone marrow could not take all the toxicity. I was discharged to my local hospital and referred to a local oncologist when I became significantly neutropenic and was therefore disqualified from the clinical trial.

At the local hospital the next day, I was fortunate to meet a compassionate oncologist who, although he did not know much about the psyche, was willing to spend time and get to know me. He learned that I cry easily, and he eventually didn’t freak out when I would suddenly start to tear up as we spoke. Another thing he learned by listening to me was that when I get sick, I have no desire to eat. I had lost 40 pounds by this time, and the doctor decided to stop pushing me to eat and instead used my good old picc line for parenteral feedings in between my ongoing chemotherapy. Once again, had a psychiatrist been working with me, I would have been much better off much more quickly.

I finally made it out of the hospital after 2 weeks, but I was so weak that I had to use a walker for quite a while just to get around and not to fall.

Now, 2 years later, I have gained my weight back (and then some). I have also regained most of my strength except for some permanent nerve damage in my legs. I also get fatigued a bit more than before. I go for outpatient monitoring and chemotherapy every 2 months, and a CT-PET scan every 6 months. I am still in remission, and I do not know what the future holds for me.
By the way, I made a mistake and did not save that little picc line that was so instrumental in saving my life. It should be in a frame over my desk. I am hopeful that I won’t have a chance to get another one.

People’s Reactions

My family and I become anxious every 2 months before my tests, but we just endure and hope. I am blessed with wonderful friends who care for me a great deal. But not one has ever said more to me about my disease than “Hi…how are you feeling? You look great.”

I am fully comfortable talking to my oncologist about my disease. If I felt the need, I would find a therapist with whom I could also talk. But, to be honest, I don’t think I could find one who could bear to hear what I might have to say—unless he or she was trained to work with cancer patients. For this reason, I strongly believe that there should be a psychiatric fellowship in oncology. If this existed, and if I knew someone who completed this course, I suspect I would go today just to talk periodically to that person. My family and friends are wonderful people, but they really can’t handle the terror that is cancer.

Because of my experiences, I can now understand much better how cancer affects the psyche. I have a private patient who is caring for a relative with metastatic lung cancer, and I am now much more able to help him deal with caring for her. There is no question in my mind that psychiatry has a vital role to play when it comes to dealing with a patient with cancer. I can only hope that psychiatry will someday respond properly—both with psychotherapy and psychotropic medications.

Clinical Pearls

Cancer is a very alienating and existential disease. I know of no other common disease that immediately causes so much fear, anxiety, depression, confusion, and a sense of impending disaster in a patient or his/her significant others when they hear the word “cancer” for the first time.

When the diagnosis is first made, the medical world quickly becomes activated. If the patient is not careful, he soon finds himself in situations that could not have been imagined. Because of this, care must be taken to give the patient time to assimilate what has happened to him. The therapist can be very helpful in facilitating this process.

By the time the diagnosis is clear, the patient has already been through a lot. The next phase is trying to figure out what the treatment options are, and which would be best for the patient. Here again, the therapist can be very helpful in overseeing this delicate and difficult process.

The tendency is to act, and not to talk, and although quick action is certainly advisable, it must not take place until the patient has had a chance to express his or her feelings. The therapist can be essential to this process.

Many patients who have cancer are facing death and they feel very isolated. The issues are so serious and frightening that the talking that usually does take place concerns the disease—not feelings. These discussions often take place between the patient and the oncologist. But this is generally not a satisfactory experience; a higher level of psychological sophistication is required. Consequently, the importance of the presence of a therapist who is not threatened or scared by cancer is all the more magnified.

A treatment team is usually involved in the care of patients with cancer. In my opinion, psychiatrists should always be part of this team; however, this is seldom the case. One way to remedy this dearth is for psychiatry residency programs to develop an oncology clerkship. Residents could learn first-hand what the cancer patient and his loved ones are going through, while learning to deal with their own difficult and uncomfortable emotions that will arise during the course of a patient’s cancer treatment.

Dr Krelstein is a board-certified psychiatrist with more than 30 years of clinical experience in a variety of public and private clinical settings. He can be contacted at mail2murray@yahoo.com. This Commentary was adapted from an article published in the June issue of Psychiatric Times. The editors of ONCOLOGY invite you to share your own experiences and thoughts regarding this topic. Please write to Rachel.Warren@ubm.com.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Don't Tell Me Anything Negative
ONCOLOGY,  May 15, 2013
A Common Theme Among Ethical Issues in Oncology: The Need to Individualize Advanced Cancer Care
ONCOLOGY,  February 15, 2013
Rationing Healthcare: Who's Responsible?
ONCOLOGY,  February 15, 2013
Ethical Challenges in Oncology, Explored Through a Series of Vignettes
ONCOLOGY,  February 15, 2013
Ethics of Cost Containment for Cancer Therapies
August 23, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Ethics In Oncology
Evidence on Ethics In Oncology
Guidelines on Ethics In Oncology
Patient Education on Ethics In Oncology
Clinical Trials on Ethics In Oncology
Practical Articles on Ethics In Oncology
Research and Reviews on Ethics In Oncology
All "Ethics In Oncology" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy